|
adenosine receptor agonist
|
CHEBI_73311 |
|
|
carbamoyl phosphate synthetase I deficiency disease
|
DOID_9280 |
|
|
Hsp90 inhibitor
|
CHEBI_63962 |
|
|
EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor
|
CHEBI_76939 |
|
|
adenosine A2A receptor agonist
|
CHEBI_73310 |
|
|
ocular hypertension
|
DOID_9282 |
|
|
hyperargininemia
|
DOID_9278 |
|
|
adenosine A3 receptor agonist
|
CHEBI_73319 |
|
|
tyrosinemia
|
DOID_9275 |
|
|
hyperhomocysteinemia
|
DOID_9279 |
|
|
estrogen receptor agonist
|
CHEBI_63951 |
|
|
acrocallosal syndrome
|
DOID_9250 |
|
|
cellulose synthesis inhibitor
|
CHEBI_63958 |
|
|
adenosine A1 receptor antagonist
|
CHEBI_63957 |
|
|
adenosine receptor antagonist
|
CHEBI_71232 |
|
|
Alagille syndrome
|
DOID_9245 |
|
|
liver disease
|
DOID_409 |
|
|
fragrance
|
CHEBI_48318 |
|
|
Pallister-Hall syndrome
|
DOID_9248 |
|
|
cerebral amyloid angiopathy
|
DOID_9246 |
|
